Skip to main content
BIOBIJOU Co., Ltd. logo

BIOBIJOU Co., Ltd. — Investor Relations & Filings

Ticker · 489460 ISIN · KR7489460006 KO Manufacturing
Open in API
Filings indexed 31 across all filing types
Latest filing 2025-05-20 Major Shareholding Noti…
Country KR South Korea
Listing KO 489460

About BIOBIJOU Co., Ltd.

http://www.biobijou.co.kr/eng/

BIOBIJOU Co., Ltd. is a biotechnology company that researches, develops, manufactures, and distributes medical aesthetic and healthcare products. The company's portfolio primarily consists of hyaluronic acid (H.A.)-based dermal fillers, injectable skin boosters, fat-dissolving solutions, and a range of cosmetic skincare items. BIOBIJOU operates across the entire value chain, from initial product development to global sales, employing automated production facilities and rigorous quality control systems. The company serves a global market, with an established international sales network and a significant distribution presence in China. It focuses on technological research and development to provide stable and high-quality products for the skincare and wellness sectors.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This specific document details a 5% threshold disclosure (or similar major shareholding notification) by 'Maisenbo Limited' regarding their stake in 'BioBijou'. According to the provided filing definitions, notifications of changes in significant share ownership levels fall under the 'Major Shareholding Notification' category.
2025-05-20 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a public offering, including subscription and allocation data for institutional and retail investors. This type of filing is a standard regulatory requirement following a capital raise and falls under the category of regulatory filings related to share issuance.
2025-05-13 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고서' (Amendment to Securities Registration Statement) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the offering price (공모가액 확정) for a public offering of shares by BioBijou Co., Ltd. This type of regulatory filing, which provides detailed terms of a securities issuance and is subject to regulatory review, falls under the 'Regulatory Filings' category as it is a formal legal disclosure document required for public offerings.
2025-05-02 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고서) for an 'Investment Prospectus' (투자설명서) filed by BioBijou Co., Ltd. It details corrections to the public offering price, total offering amount, and allocation ratios for a KOSDAQ listing. In the context of financial filings, a prospectus or its amendment is a core regulatory document related to capital raising and share issuance. Since it is a formal regulatory filing for a public offering and does not fit into the specific categories of 'Annual Report' or 'Earnings Release', and is not merely an announcement of a report, it is classified as a Regulatory Filing (RNS).
2025-05-02 Korean
투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '투자설명서' (Investment Prospectus) for a company named 'BioBijou' (주식회사 바이오비쥬). It contains detailed information regarding a public offering of 3,000,000 shares, including offering price, subscription periods, risk factors, and financial information. In the context of financial filings, a prospectus is a formal document required by regulatory bodies (like the FSC/FSS in Korea) for securities offerings. Among the provided categories, this document fits best as a 'Regulatory Filing' (RNS) as it is a formal legal disclosure document for a public offering that does not fall into the specific categories of Annual Reports, Earnings Releases, or Proxy Statements.
2025-04-29 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by BioBijou. It details amendments to a previously filed securities registration statement, including updates to investment risk factors and underwriter opinions. This is a formal regulatory filing required for an IPO or public offering of securities in South Korea, which falls under the category of regulatory filings for securities registration.
2025-04-18 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.